Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6092883 | Gastroenterology | 2016 | 45 Pages |
Abstract
Concentrations of FCP correlate with clinical and endoscopic outcomes of patients with moderate to severe ulcerative colitis receiving tofacitinib, although at an individual level the agreement was moderate. FCP concentration with a cut-off value of 150 mg/kg had only fair to good accuracy in classifying clinical and endoscopic outcomes in a clinical trial. ClinicalTrials.gov no: NCT00787202.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
William J. Sandborn, Julian Panés, Haiying Zhang, Dahong Yu, Wojciech Niezychowski, Chinyu Su,